OPPORTUNITY™: A Randomized Clinical Trial of Growth Hormone on Outcome in Hemodialysis Patients

Background: The mortality rate of maintenance hemodialysis (MHD) patients remains high. Measures of protein-energy wasting, including hypoalbuminemia, are strongly associated with their high mortality. Growth hormone (GH) may improve lean body mass (LBM) and serum albumin levels, and health-related...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kopple, Joel D., Cheung, Alfred K., Christiansen, Jens Sandahl, Djurhuus, Christian Born, El Nahas, Meguid, Feldt-Rasmussen, Bo, Lange, Martin, Mitch, William E., Wanner, Christoph, Wiedemann, Jonas, Ikizler, T. Alp
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Nephrology 2008
Предметы:
Dialysis
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2572295/
https://ncbi.nlm.nih.gov/pubmed/18945992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.02760608
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы